Neurona Therapeutics
Sarka Lostakova currently serves as the Corporate Controller at Neurona Therapeutics since May 2024. Prior to this role, Sarka was the Assistant Controller at Shockwave Medical from September 2022 to April 2024, where responsibilities included overseeing monthly accounting processes, SEC reporting, and ERP system implementation. Sarka also held the position of Assistant Controller at Sutro Biopharma, Inc. from June 2021 to August 2022, leading SOX 404 implementation and managing financial close procedures. Sarka's extensive experience in auditing spans over a decade at EY, where roles included Audit Senior Manager and Audit Manager, focusing on financial statements under US GAAP and IFRS, SEC reporting, and SOX compliance across various industries. Sarka holds multiple degrees, including an Mgr. in Law from Charles University and a Bachelor's in International Trade from Prague University of Economics and Business.